Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier

Several large population-based or clinical trial studies have suggested that certain dihydropyridine (DHP) L-type calcium channel blockers (CCBs) used for the treatment of hypertension may confer protection against the development of Alzheimer disease (AD). However, other studies with drugs of the s...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Paris, Daniel, Bachmeier, Corbin, Patel, Nikunj, Quadros, Amita, Volmar, Claude-Henry, Laporte, Vincent, Ganey, Jim, Beaulieu-Abdelahad, David, Ait-Ghezala, Ghania, Crawford, Fiona, Mullan, Michael J
Format: Artigo
Jezik:Inglês
Izdano: ScholarOne 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3060987/
https://ncbi.nlm.nih.gov/pubmed/21170472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2010.00180
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki